amantadine has been researched along with Viremia in 4 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Viremia: The presence of viruses in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an attempt to improve the efficacy of antiviral therapy for chronic hepatitis C, a three-drug combination of pegylated interferon alpha-2b, ribavirin, and amantadine has been suggested." | 9.11 | Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C. ( Barnes, DS; Bringman, D; Carey, WD; Farmer, D; Ferguson, R; Gramlich, T; Levinthal, G; Martin, LM; McCullough, AC; Mullen, KD; O'Shea, R; Ong, JP; Post, A; Tavill, AS; Younossi, ZM, 2005) |
| "After 6 months of amantadine therapy (200 mg per day), there were no decrease in HCV viremia (5." | 5.11 | Amantadine therapy in renal transplant patients with hepatitis C virus infection. ( Durand, D; Izopet, J; Kamar, N; Ribes, D; Rostaing, L; Sandres-Saune, K, 2004) |
| "In an attempt to improve the efficacy of antiviral therapy for chronic hepatitis C, a three-drug combination of pegylated interferon alpha-2b, ribavirin, and amantadine has been suggested." | 5.11 | Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C. ( Barnes, DS; Bringman, D; Carey, WD; Farmer, D; Ferguson, R; Gramlich, T; Levinthal, G; Martin, LM; McCullough, AC; Mullen, KD; O'Shea, R; Ong, JP; Post, A; Tavill, AS; Younossi, ZM, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leroy, V | 1 |
| Hilleret, MN | 1 |
| Kamar, N | 1 |
| Rostaing, L | 1 |
| Sandres-Saune, K | 1 |
| Ribes, D | 1 |
| Durand, D | 1 |
| Izopet, J | 1 |
| Younossi, ZM | 1 |
| McCullough, AC | 1 |
| Barnes, DS | 1 |
| Post, A | 1 |
| Ong, JP | 1 |
| O'Shea, R | 1 |
| Martin, LM | 1 |
| Bringman, D | 1 |
| Farmer, D | 1 |
| Levinthal, G | 1 |
| Mullen, KD | 1 |
| Carey, WD | 1 |
| Tavill, AS | 1 |
| Ferguson, R | 1 |
| Gramlich, T | 1 |
| Lieb, K | 1 |
| Staeheli, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients[NCT00146016] | Phase 3 | 390 participants | Interventional | 2000-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amantadine and Viremia
| Article | Year |
|---|---|
[Evaluation of response to treatment in chronic hepatitis C].
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Clinical Enzy | 2002 |
Borna disease virus--does it infect humans and cause psychiatric disorders?
Topics: Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Borna Disease; Borna disease virus; Brain; | 2001 |
2 trials available for amantadine and Viremia
| Article | Year |
|---|---|
Amantadine therapy in renal transplant patients with hepatitis C virus infection.
Topics: Adult; Alanine Transaminase; Amantadine; Antiviral Agents; Aspartate Aminotransferases; Cyclosporine | 2004 |
Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
Topics: Adult; Amantadine; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female | 2005 |